Bay Area Youth to Represent ALS Patients at Giants' and Angels' Baseball Games o...(S TDI Augie's Quest (the Muscular Dystro...)

Date:7/3/2009

S TDI, Augie's Quest (the Muscular Dystrophy Association's ALS research initiative) and Project A.L.S. -- whose primary goal is to find a cure for ALS. The initiative will culminate on July 4, 2009, which is the 70th anniversary of Lou Gehrig's famous farewell speech at Yankee Stadium. ALS destroys the nerve cells controlling muscles, ultimately causing complete paralysis. Average life expectancy is three to five years after diagnosis.

"Corey is an amazing and positive young man. He and his family have impacted us greatly at ALS TDI. We are very lucky to have an opportunity to know him and have his family's support for our work. It is heartbreaking that there is so little that can be done for young men and women like Corey today. That is unacceptable, and we must not stop until we have a better answer for all ALS patients," said Steve Perrin, Ph.D., Chief Executive Officer and Chief Scientific Officer at ALS TDI.

Although Corey is a life-long Oakland Athletics fan, he and his father Ted, mother Wendy, and sister Clare, will take part in a pre-game celebration honoring Lou Gehrig and ALS patients that are currently battling the disease at the start of the San Francisco Giants game. Corey will then board a plane to Anaheim to arrive just before game time at the "Big A" to see the Angels play the Baltimore Orioles. At the Angels' game, Corey will again enter onto the field with other ALS patients to repeat a similar ceremony in the Angels' stadium and then spend the rest of the day with other ALS patients and advocates attending the game as well.

More information on Corey and his efforts can be found online at www.coreyscrusaders.alscommunity.org. The "4ALS Awareness" campaign is a joint effort between four ALS organizations; the ALS Association, the MDA/Augie's Quest, Project ALS, and ALS TDI. More information is available on the Off
'/>"/>

SOURCE ALS Therapy Development Foundation Copyright©2009 PR Newswire. All rights reserved

3 GOOD

Page: 1 2 3
Related biology technology :

1. Encision Enters Into Sales Representation Agreement With Caldera Medical
2. Air Transport Association Applauds House of Representatives on Decision to Withhold Biometric Collection Funding
3. JD Technologies, LLC Selected by FCT Ingenieurkeramik GmbH to Represent Their High Performance Ceramic Expertise In the United States
4. CMR Institute: Education Key to Physician/Representative Relationship
5. Microfluidic Systems to Show Automated Biological Agent Detection Technology to U.S. House of Representatives
6. 125 Indevus Sales Representatives to Provide Community Service in New Orleans for Jericho Road Episcopal Housing Initiative
7. Experts and Representatives From Leading International Health-Care Organizations Call to Stop the Hypertension Pandemic, a Worldwide Silent Killer
8. ThalesNano Inc. Opens Own Representation in the United Kingdom and has New Distribution Agreements for Europe and India
9. OncoGenex Pharmaceuticals Completes Amendment to Phase 3 Special Protocol Assessment for Confirming Survival Benefit in Patients Receiving OGX-011 with First-Line Docetaxel for Metastatic Prostate Cancer
10. YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB
11. Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia